ALT
Altimmune, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.
Market Cap: 44.5 Million
Primary Exchange: NASDAQ
Website: http://www.altimmune.com
Shares Outstanding: 15.4 Million
Float: 12.7 Million
Dividend: (%)
Beta: -0.272294465960171
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Ethical Flags
Longest drawdown: 825 trading days
From: 2017-01-10 To: 2020-04-03
Lowest Point:
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-05-05 | 10.0 | 1.0 | 10.0 |